Humacyte, Inc. announced plans to file an Investigational New Drug (IND) application with the FDA, aiming to conduct first-in-human clinical trials of its small-diameter acellular tissue engineered ...
CLEVELAND — When one thinks of heart bypass surgery-- a long chest scar, months of recovery, pain and often fear come to mind. Since December, about 55 patients have received a new, robotic approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results